One Platform.

Faster ECG Interpretation.

Earlier Cardiac Insights.

Connect any ECG device. Deploy any algorithm. Integrate with any EHR. MyoVista Insights analyzes ECGs from any device to surface cardiac dysfunction that standard interpretation misses.

MyoVista Insights - AI-ECG Analysis Dashboard

40%

Faster interpretation

(Mount Sinai, 2024)

87%

Sensitivity

(JACC, 2024)

What is MyoVista Insights?

MyoVista Insights is an AI-powered ECG analysis platform that transforms standard 12-lead ECGs into actionable cardiac insights. Using advanced machine learning trained on millions of ECGs, it detects conditions often missed by traditional interpretation.

Multi-condition detection - Screens for 20+ cardiac conditions including left ventricular dysfunction and hypertrophic cardiomyopathy

Instant risk stratification - Prioritize patients who need immediate attention with confidence scores

Seamless EHR integration - Results flow directly into Epic, Cerner, MEDITECH, and other major systems

Learn more about our products
MyoVista Insights Dashboard - AI-ECG Analysis Interface

Enterprise-Ready Features

Built for healthcare organizations that demand reliability, security, and seamless integration

Vendor Neutral

Works with GE, Philips, Nihon Kohden, and any ECG device. No hardware lock-in, complete flexibility.

Cloud Native

Scalable AWS infrastructure with 99.9% uptime SLA. Auto-scaling to handle any volume.

AI Orchestration

Deploy multiple algorithms simultaneously. Mix and match AI models for comprehensive analysis.

EHR Integration

Native HL7 FHIR support. Pre-built connectors for Epic, Cerner, and all major EHR systems.

Real-time Processing

Results delivered in under 30 seconds. Immediate actionable insights for clinical workflows.

HIPAA Compliant

Enterprise-grade security with SOC 2 Type II certification. End-to-end encryption for all data.

What Our Customers Say

Healthcare leaders share their success stories

"AI-ECG has significantly improved our cardiology department. We're catching conditions weeks earlier than before."
SC

Dr. Sarah Chen

Chief of Cardiology

Mount Sinai Health System

"We went from being skeptical to becoming advocates in just one month. The improvement in our cardiac care has been remarkable."
JR

Dr. James Rodriguez

Medical Director

Cibolo Health

Evidence-Based AI

Clinically Validated

Our AI-ECG algorithms are backed by peer-reviewed research and validated across thousands of patients.

40%
Faster Interpretation
Mount Sinai Study, 2024
87%
Sensitivity for Cardiac Dysfunction
JACC: Heart Failure, 2024
23+
Peer-Reviewed Publications
JACC, Circulation, EHJ
8.5M+
ECGs Analyzed
12+
Clinical Partners
FDA
510(k) Cleared
JACC
Journal of the American College of Cardiology
Circ
Circulation
EHJ
European Heart Journal
Heart
Heart Journal

Ready to Improve Cardiac Detection?

See how 12 validated algorithms can help your clinicians detect cardiac dysfunction earlier. Schedule a 30-minute demo with our clinical team.

30-minute demo
Clinical evidence review
Custom pricing